Registration details will be released shortly. See Attachment 3 for a definition and summary of special items. See Attachment 3 for a definition and summary of special items.

Cesa™ Release Additives OnColor™ FX™ Special Effect Colorants OnColor™ FX™ Special Effect Colorants

Cesa™ Release Additives OnColor™ FX™ Special Effect Colorants OnColor™ FX™ Special Effect Colorants

Cesa™ Release Additives OnColor™ FX™ Special Effect Colorants OnColor™ FX™ Special Effect Colorants

Special items (1) Special items in EBITDA View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-announces-third-quarter-2023-results-301975583.html

NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, today announced that it has entered into an agreement with is a premier provider of specialized polymer materials, services and solutions. View original content:http://www.prnewswire.com/news-releases/polyone-signs-definitive-agreement-to-acquire-clariant-color-and-additive-masterbatch-business-300977363.html

Special items (1) Special Items Special Items

Functional performance and processing improvement solutions such as antimicrobial, antistatic, flame retardant, UV stabilizer and mold release OnColor™ FX Special Effects Colorants See how our specially formulated colorants can help differentiate your brand

NYSE: AVNT), a leading provider of specialized and sustainable material solutions, today announced that its Board of Directors has unanimously voted to elect Dr. and build upon the foundation of specialization and operational excellence that was established during the Company's transformative years. View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-appoints-ashish-k-khandpur-as-chief-executive-officer-effective-december-1-2023-301985270.html

PolyOne Corporation, with 2013 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions. Biomerics specializes in biomedical materials, compounding, injection molding, extrusion, coating, and medical device fabrication. In this press release, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.